Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of MAB-22 Versus Prolia®
Clinical trial NCT06504966 · WITHDRAWN
Trial details
- NCT number
- NCT06504966
- Sponsor
- Xentria, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2027-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.